DSE AntibodyRabbit Polyclonal
|In-house applications||ELISA, IHC Application not tested? Please see our Guarantee.|
|Published applications||IF, IHC||Publications||1 citations –view here|
|Species specificity||Human; other species not tested.|
|Positive IHC detected in||human liver cancer tissue|
|Recommended dilution||IHC : 1:20-1:200|
IP = Immunoprecipitation
|Source||Rabbit||Purification method||Antigen affinity purification|
PBS with 0.1% sodium azide and 50% glycerol pH 7.3. Store at -20oC.
Aliquoting is unnecessary for -20oC storage
|Immunogen||DSE fusion protein ag0695||Full name||dermatan sulfate epimerase|
|958 aa,110 kDa||
|BC039245||Gene ID (NCBI)||29940|
|Gene symbol||DSE||Synonyms||dermatan sulfate epimerase, DS epimerase, DSE, DSEPI, SART 2, SART2|
DSE, also named as SART2 and DSEPI, is an enzyme that converts D-glucuronic acid to L-iduronic acid residues in dermatan sulphate biosynthesis. It is also identified to be a tumour-associated antigen. DSE is recognized by cytotoxic T cells (CTLs) and its enhanced expression in many cancers has been reported. DSE is a potential candidate for a tumour antigen with immunogenicity.